Molecular biology of high-grade gliomas: what should the clinician know? - Wikidata - wikimedia - TriplyDB

Molecular biology of high-grade gliomas: what should the clinician know?

Molecular biology of high-grade gliomas: what should the clinician know?

http://www.wikidata.org/entity/Q27009190

about

Clinical management of grade III oligodendroglioma Progressive multifocal exophytic pontine glioblastoma: a case report with literature review.Heavy metals and epigenetic alterations in brain tumors.The future of high-grade glioma: Where we are and where are we going.Secreted and O-GlcNAcylated MIF binds to the human EGF receptor and inhibits its activation Driver or passenger effects of augmented c-Myc and Cdc20 in gliomagenesis.Anaplastic glioma: current treatment and management.Beyond the World Health Organization grading of infiltrating gliomas: advances in the molecular genetics of glioma classification.MIR-491: CDKN2A tumor suppressor co-pilot.Pediatric spinal glioblastoma of the conus medullaris: a case report of long survival.High-grade gliomas: reality and hopes.Expression and Prognostic Significance of p53 in Glioma Patients: A Meta-analysis.

P2860

Q26801254-51AEEE5E-479C-4BCC-BEBC-56055027223B Q30360104-13FE34DC-2AA4-4FEE-816D-62E23B6CDAFD Q35029941-D8991EE4-2276-461B-B3B9-29869EF061C6 Q35114090-E7AB10ED-8CCE-4C75-93F7-5EAD54445C0D Q36672321-F04161E9-F30F-475B-BADE-9D5F1054D1DA Q37269061-4EC10C27-E143-4716-A913-D0916636BF1F Q38456018-BCA6A26A-7790-488D-96C8-A7BC460929CB Q38504172-4AC4496E-27BB-4032-8789-7D8B69A50038 Q40196549-AF9F1402-57A7-4A18-88D8-60F3F69250EB Q41263837-82DE05D7-30E2-4B35-96D1-F607AD7631E4 Q42731893-BF00926A-24F4-495C-B651-E96CBBEC088B Q52142503-DF730BF2-9FA6-456B-89CC-CB97DC8DE3DE

P2860

Molecular biology of high-grade gliomas: what should the clinician know?

http://www.wikidata.org/entity/Q27009190

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Molecular biology of high-grade gliomas: what should the clinician know?

@ast

Molecular biology of high-grade gliomas: what should the clinician know?

@en

Molecular biology of high-grade gliomas: what should the clinician know?

@nl

type

label

Molecular biology of high-grade gliomas: what should the clinician know?

@ast

Molecular biology of high-grade gliomas: what should the clinician know?

@en

Molecular biology of high-grade gliomas: what should the clinician know?

@nl

prefLabel

Molecular biology of high-grade gliomas: what should the clinician know?

@ast

Molecular biology of high-grade gliomas: what should the clinician know?

@en

Molecular biology of high-grade gliomas: what should the clinician know?

@nl

P1433

Q27009190-5B9CBBFB-B6BC-48C4-96E6-BEB043B04279

P1476

Q27009190-4935E1CA-2CF4-4C86-8385-86B11E0F8B02

P2093

Q27009190-354FDB82-3B07-4D75-BF39-30DFB89A6A99

Q27009190-7BF08AF2-6040-4E10-B267-E8B44272947E

Q27009190-87EEC534-8514-4BA1-A00A-703BD8D27C6E

P275

Q27009190-C0AC8716-A5AD-455E-970C-F6A84E9EA21E

P2860

Q27009190-02B954E6-218F-44D7-8171-CDF3375D7F13

Q27009190-03115B5E-C53E-4FAB-A83B-F9A9AC34581C

Q27009190-21DE4E8A-EDC0-41DD-8FF4-85AC47A7374E

Q27009190-261CC595-28A2-4D47-89C3-BB9046FDE0E9

Q27009190-465FB439-CBBE-4AD4-A0F5-C81F04296870

Q27009190-4B9B347E-896F-4967-AF2A-1F2EDA028B4F

Q27009190-4E96AA1E-BEA7-4505-BDCB-2773B8FDBA2F

Q27009190-67961454-2E69-41E7-A106-742C7BE51F64

Q27009190-6A6B408D-0CA6-4F17-A0CD-6C30EF4CFEB5

Q27009190-78BDF6ED-C071-49AD-9642-B222880CFE77

P304

Q27009190-CAB7F8C6-131E-450C-BB4F-628BF9EA8FDD

P31

Q27009190-BF3734FD-166A-4076-96CF-E2537D2B61F0

P3181

Q27009190-D896B30F-AEE0-4941-8FAC-2D5056F1D948

P356

Q27009190-2ABE6351-E9C2-4956-87B3-EB7ABC572838

P407

Q27009190-EF1C778B-61AE-464D-B03D-2100487198E2

P433

Q27009190-FE562059-9A77-4E83-8B53-624B6445DC0B

P478

Q27009190-88E25F97-AD78-45E3-B122-587EDF2510F8

P50

Q27009190-3184B87D-B188-43CF-B63A-20D7CD2C9C41

P5008

Q27009190-D62ADA3F-5990-43E8-BB87-CC190B17F4E4

P577

Q27009190-91D0AC00-D344-41C8-8990-13560D4B93BA

P5875

Q27009190-2C1FB0CA-B413-4132-BC09-43C8FCEFDDC2

P698

Q27009190-2B88B2FC-3B03-4A00-8C15-04A93051FD82

P921

Q27009190-0283871E-7456-420F-98BC-2A0B4F2F628B

Q27009190-0AE97FAB-D271-43F1-BF0F-27E28E0E0BDB

Q27009190-3492B749-77C3-4745-A06F-F19EE9FC08BA

Q27009190-46392870-2E15-441C-B3F4-90DB8F7A82D4

Q27009190-C2112EF4-AF19-49CD-B132-5D4EF2A8D831

Q27009190-CF84AEDD-477A-4CB5-91BB-1A5012DA76CC

Q27009190-EFB2D473-6757-4D62-A098-BA9E05EC5B66

P932

Q27009190-95B0FE61-631D-4393-AD17-FE7DB71F8C55

P3181

P356

P1433

Chinese Journal of Cancer

P1476

Molecular biology of high-grade gliomas: what should the clinician know?

@en

P2093

Christine Marosi

http://www.w3.org/2001/XMLSchema#string

Elisabeth Rushing

http://www.w3.org/2001/XMLSchema#string

Silvia Hofer

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported

P2860

The 2007 WHO classification of tumours of the central nervous system

The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.

Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial.

Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial.

Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?

Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide era.

Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.

P304

4-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1778993

http://www.w3.org/2001/XMLSchema#string

P356

10.5732/CJC.013.10218

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

Matthias Preusser

P5008

P577

2013-12-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259270143

http://www.w3.org/2001/XMLSchema#string

P698

24325789

http://www.w3.org/2001/XMLSchema#string

P921

chromosomal deletion syndrome

genetic variation

neoplasm proteins

P932

3905084

http://www.w3.org/2001/XMLSchema#string